Baudax Bio (BXRXQ)
OTHER OTC:BXRXQ
US Market
Holding BXRXQ?
Track your performance easily

Baudax Bio (BXRXQ) Financial Statements

754 Followers

Baudax Bio Financial Overview

Baudax Bio's market cap is currently ―. The company's EPS TTM is $-9.164; its P/E ratio is >-0.01; Baudax Bio is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue---$ 309.00K$ 238.00K
Gross Profit$ -43.00K$ -74.00K$ -391.00K$ -5.49M$ -970.00K
EBIT$ -5.54M$ -4.03M$ -4.69M$ -9.25M$ -4.09M
EBITDA$ -5.41M$ -4.03M$ -4.68M$ -9.14M$ -4.08M
Net Income Common Stockholders$ -2.39M$ -7.38M$ 11.40M$ -9.25M$ -29.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 363.00K$ 1.42M$ 3.80M$ 5.26M$ 5.65M
Total Assets$ 20.58M$ 21.32M$ 7.07M$ 10.03M$ 17.51M
Total Debt$ 8.10M$ 8.77M$ 7.43M$ 7.12M$ 8.09M
Net Debt$ 7.73M$ 7.36M$ 3.63M$ 1.86M$ 2.44M
Total Liabilities$ 21.78M$ 32.00M$ 14.38M$ 34.27M$ 37.05M
Stockholders Equity$ -10.24M$ -10.68M$ -7.31M$ -24.24M$ -19.54M
Cash Flow-
Free Cash Flow$ -2.43M$ -3.45M$ -4.66M$ -3.78M$ 7.09M
Operating Cash Flow$ -2.41M$ -3.45M$ -4.66M$ -1.02M$ 7.09M
Investing Cash Flow$ -21.00K$ 333.00K-$ -2.76M$ -46.00K
Financing Cash Flow$ 1.38M$ 917.00K$ 3.21M$ 3.40M$ 5.53M
Currency in USD

Baudax Bio Earnings and Revenue History

Baudax Bio Debt to Assets

Baudax Bio Cash Flow

Baudax Bio Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis